WSAZ-TV |
Mylan CEO defends price boosts for lifesaving EpiPen
USA TODAY But based on the volume of sales, it's a "considerable profit for the company," Udow-Phillips told USA TODAY. "Taking her $50 per EpiPen at face value, I would describe that as a very good (profit) margin on a product where we know the drug itself ... USA Today reports Gayle Manchin used position to boost EpiPen sales Family matters: EpiPens had high-level help getting into schools How Much Has Medicare Spent on the EpiPen Since 2007? |
